Comparison of Humidification Devices During Non Invasive Ventilation, in Acute Respiratory Failure

• -Physiological outcome at 1,3 and 6 hours (arterial blood gases, respiratory rate) [ Time Frame: during the study ] [ Designated as safety issue: Yes ]
• -Intolerance of NIV [ Time Frame: during the study ] [ Designated as safety issue: Yes ]
• - Frequency of VAP [ Time Frame: during the study ] [ Designated as safety issue: Yes ]
• - Duration of total MV duration [ Time Frame: during the study ] [ Designated as safety issue: Yes ]
• - ICU LOS [ Time Frame: during the study ] [ Designated as safety issue: Yes ]
• - Hospital LOS [ Time Frame: during the study ] [ Designated as safety issue: Yes ]
• - Mortality (ICU and hospital) [ Time Frame: during the study ] [ Designated as safety issue: Yes ]

• -Physiological outcome at 1,3 and 6 hours (arterial blood gases, respiratory rate)
• -Intolerance of NIV
• - Frequency of VAP
• - Duration of total MV duration
• - ICU LOS
• - Hospital LOS
• - Mortality (ICU and hospital)

Comparison of humidification devices during non invasive ventilation, in acute respiratory failure.

The hypothesis was, due to dead space, lower humidification, a reduced efficiency of the technique (NIV) when HME are used in comparison with HH.

Comparison of humidification devices during non invasive ventilation, in acute respiratory failure.

The hypothesis was, due to dead space, lower humidification, a reduced efficiency of the technique (NIV) when HME are used in comlparison with HH Several physiological previously performed showed that 1) with HME, because of its working principles, humidification was reduced because of leaks 2) work of breathing was increased with HME because of dead space and 3) alveolar ventilation was reduced with HME because of additional technical dead space.

For these reasons, the hypothesis was an improvement of NIV tolerance, of efficiency to clear te CO2 with HH in comparison with HME and finally to reduce the intubation rate with HH.

The patients were included when requiring NIV (see inclusion and exclusion criteria) and randomisation was performed with stratification according to presence or absence of respiratory acidosis.

The number of patients to include was baszd on the hypothesis that intubation rate would be reduced from 40 with HME to 25% with HME. A total of 250 patients was required with alpha risk of 0,05 and beta risk of 0,2 (power 80%). Intubation criteria were predefined according to the litterature. The expected duration was 18 months. The official support was institutional (DRRC of AP-HP). HH were furnished free of charge, as well as HME. Masks used were the same in both groups.

• Respiratory Failure
• COPD
• Hypoxemia
• Non Invasive Ventilation

Inclusion Criteria:

• Age between 18 and 85 years
• Exacerbation of dyspnea lasting less than two weeks

TWO OR THREE following criteria :

• Respiratory rate higher or equal to 25 b/min
• SaO2 lower or equal to 90% (breathing room air or oxygen)
• Arterial pH < 7.35

Exclusion Criteria:

• immediate need for intubation
• cardiac arrest or RR< 10 breaths/min.
• systemic hypotension (SAP < 80 mmHg ) with no response to 500 ml of macromolecules
• coma defined by GCS < 8.
• high probability of surgical procedure
• major facial deformity
• pneumothorax
• bad short-term prognosis
• refusal of intubation by the patient or do not intubated order.